Emergent BioSolutions CEO Bob Kramer joined Jim Cramer on “Mad Money” to discuss the biopharmaceutical company’s role in the quest to bring a Covid-19 vaccine to market.
{iframe}https://www.cnbc.com/video/2020/08/12/emergent-biosolutions-ceo-on-johnson-johnson-astrazeneca-vaccine-partnerships.html{/iframe}